A systematic review of adult tetanus-diphtheria-acellular (Tdap) coverage among healthcare workers

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorRANDI, Bruno A.
dc.contributor.authorSEJAS, Odeli Nicole Encinas
dc.contributor.authorMIYAJI, Karina T.
dc.contributor.authorINFANTE, Vanessa
dc.contributor.authorLARA, Amanda N.
dc.contributor.authorIBRAHIM, Karim Y.
dc.contributor.authorLOPES, Marta H.
dc.contributor.authorSARTORI, Ana Marli C.
dc.date.accessioned2019-03-26T14:29:34Z
dc.date.available2019-03-26T14:29:34Z
dc.date.issued2019
dc.description.abstractDuring the last decades pertussis incidence raised globally. Several vaccination strategies targeting adults to reduce pertussis among young infants have been proposed, including vaccination of healthcare workers (HCWs). The aim of this study was to analyse, by performing a systematic review of literature, published papers that evaluated Tdap coverage among HCWs, variables associated with vaccine uptake and efforts implemented to raise vaccination rates. We searched the MedLine, Embase, SCOPUS, LILACS, Web of Science and Cochrane for full-text studies that evaluated Tdap coverage in HCW. Two independent reviewers screened the articles and extracted the data. Twenty-eight studies published from 2009 to 2018 were reviewed. Most studies were conducted in the USA. Initial Tdap coverage varied from 6.1% to 63.9%. USA and France are the only two countries with studies evaluating Tdap coverage within HCWs using national data. In the USA, Tdap coverage in HCWs raised from 6.1% to 45.1% from 2007 to 2015. In the analysis of French national data, a Tdap coverage of 63.9% was observed. Five studies used interventions to raise Tdap coverage in HCWs. Two intervention studies implemented mandatory vaccination and three used educational strategies. All of them achieved coverages over 86%. Only eleven studies analysed the association of Tdap vaccination with variables of interest. Previous immunization with other vaccines recommended for HCWs (like influenza, hepatitis B and MMR) was positively associated with Tdap uptake in four studies. In conclusion, overall Tdap coverage among HCWs is low, but seems to increase over the years after the vaccine introduction and with implementation of interventions to increase coverage.eng
dc.description.indexMEDLINEeng
dc.identifier.citationVACCINE, v.37, n.8, p.1030-1037, 2019
dc.identifier.doi10.1016/j.vaccine.2018.12.046
dc.identifier.eissn1873-2518
dc.identifier.issn0264-410X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/31159
dc.language.isoeng
dc.publisherELSEVIER SCI LTDeng
dc.relation.ispartofVaccine
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright ELSEVIER SCI LTDeng
dc.subjectDiphtheria-tetanus-pertussis vaccineeng
dc.subjectBordetella pertussiseng
dc.subjectHealth personneleng
dc.subjectImmunizationeng
dc.subjectVaccinationeng
dc.subjectWhooping cougheng
dc.subject.otherpertussis vaccination coverageeng
dc.subject.otherunited-stateseng
dc.subject.othernosocomial pertussiseng
dc.subject.otherimmunizationeng
dc.subject.otheroutbreakeng
dc.subject.othersurveillanceeng
dc.subject.otherpopulationseng
dc.subject.otherhospitalseng
dc.subject.otherinfluenzaeng
dc.subject.otherproviderseng
dc.subject.wosImmunologyeng
dc.subject.wosMedicine, Research & Experimentaleng
dc.titleA systematic review of adult tetanus-diphtheria-acellular (Tdap) coverage among healthcare workerseng
dc.typearticleeng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.citation.scopus15
hcfmusp.contributor.author-fmusphcBRUNO AZEVEDO RANDI
hcfmusp.contributor.author-fmusphcODELI NICOLE ENCINAS SEJAS
hcfmusp.contributor.author-fmusphcKARINA TAKESAKI MIYAJI
hcfmusp.contributor.author-fmusphcVANESSA INFANTE
hcfmusp.contributor.author-fmusphcAMANDA NAZARETH LARA
hcfmusp.contributor.author-fmusphcKARIM YAQUB IBRAHIM
hcfmusp.contributor.author-fmusphcMARTA HELOISA LOPES
hcfmusp.contributor.author-fmusphcANA MARLI CHRISTOVAM SARTORI
hcfmusp.description.beginpage1030
hcfmusp.description.endpage1037
hcfmusp.description.issue8
hcfmusp.description.volume37
hcfmusp.origemWOS
hcfmusp.origem.pubmed30630694
hcfmusp.origem.scopus2-s2.0-85059538731
hcfmusp.origem.wosWOS:000458709200004
hcfmusp.publisher.cityOXFORDeng
hcfmusp.publisher.countryENGLANDeng
hcfmusp.relation.referenceBaggett HC, 2007, INFECT CONT HOSP EP, V28, P537, DOI 10.1086/513497eng
hcfmusp.relation.referenceBaron-Epel O, 2013, HUM VACC IMMUNOTHER, V9, P100, DOI 10.4161/hv.22503eng
hcfmusp.relation.referenceBohmer MM, 2013, DEUT MED WOCHENSCHR, V138, P1451, DOI 10.1055/s-0033-1343249eng
hcfmusp.relation.referenceBoulay BR, 2006, INFECT CONT HOSP EP, V27, P92, DOI 10.1086/500420eng
hcfmusp.relation.referenceCalderon TA, 2015, J PEDIAT INF DIS SOC, V4, P252, DOI 10.1093/jpids/piu056eng
hcfmusp.relation.referenceCalugar A, 2006, CLIN INFECT DIS, V42, P981, DOI 10.1086/500321eng
hcfmusp.relation.referenceCarande-Kulis VG, 2000, AM J PREV MED, V18, P75, DOI 10.1016/S0749-3797(99)00120-8eng
hcfmusp.relation.referenceCenters for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P67eng
hcfmusp.relation.referenceDEVILLE JG, 1995, CLIN INFECT DIS, V21, P639, DOI 10.1093/clinids/21.3.639eng
hcfmusp.relation.referenceDomenech de Celles M, 2016, P BIOL SCI, V283eng
hcfmusp.relation.referenceDuclos A, 2008, J EVAL CLIN PRACT, V14, P610, DOI 10.1111/j.1365-2753.2008.00946.xeng
hcfmusp.relation.referenceEden J, 2011, FIND WHAT WORKS HLTH, P317eng
hcfmusp.relation.referenceEsolen LM, 2013, AM J INFECT CONTROL, V41, P740, DOI 10.1016/j.ajic.2012.10.012eng
hcfmusp.relation.referenceForsyth K, 2015, PEDIATRICS, V135, pE1475, DOI 10.1542/peds.2014-3925eng
hcfmusp.relation.referenceGabutti G, 2015, HUM VACC IMMUNOTHER, V11, P108, DOI 10.4161/hv.34364eng
hcfmusp.relation.referenceHaviari S, 2015, HUM VACC IMMUNOTHER, V11, P2522, DOI 10.1080/21645515.2015.1082014eng
hcfmusp.relation.referenceHees L, 2009, ARCH PEDIATRIE, V16, P14, DOI 10.1016/j.arcped.2008.10.017eng
hcfmusp.relation.referenceHiggins JPT, 2011, COCHRANE HDB SYSTEMA, DOI 10.1002/9780470712184eng
hcfmusp.relation.referenceJiang CH, 2018, VACCINE, V36, P214, DOI 10.1016/j.vaccine.2017.11.071eng
hcfmusp.relation.referenceKassianos George, 2015, Drugs Context, V4, P212268, DOI 10.7573/dic.212268eng
hcfmusp.relation.referenceLa Torre G, 2017, HEALTHCARE, V5, DOI 10.3390/healthcare5010013eng
hcfmusp.relation.referenceLeibu R, 2015, J OCCUP ENVIRON MED, V57, P58, DOI 10.1097/JOM.0000000000000294eng
hcfmusp.relation.referenceLoulergue P, 2009, VACCINE, V27, P4240, DOI 10.1016/j.vaccine.2009.03.039eng
hcfmusp.relation.referenceLoulergue P, 2013, VACCINE, V31, P2835, DOI 10.1016/j.vaccine.2013.04.004eng
hcfmusp.relation.referenceLu PJ, 2014, VACCINE, V32, P572, DOI 10.1016/j.vaccine.2013.11.077eng
hcfmusp.relation.referenceMacDougall D, 2015, HUM VACC IMMUNOTHER, V11, P2167, DOI 10.1080/21645515.2015.1046662eng
hcfmusp.relation.referenceMacDougall DM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009062eng
hcfmusp.relation.referenceMaltezou HC, 2014, VACCINE, V32, P4876, DOI 10.1016/j.vaccine.2013.10.046eng
hcfmusp.relation.referenceMiller B. L., 2010, Morbidity and Mortality Weekly Report, V59, P1302eng
hcfmusp.relation.referenceMiller BL, 2011, VACCINE, V29, P3850, DOI 10.1016/j.vaccine.2011.03.058eng
hcfmusp.relation.referenceNowalk MP, 2016, VACCINE, V34, P5026, DOI 10.1016/j.vaccine.2016.07.053eng
hcfmusp.relation.referenceO'Halloran AC, 2018, AM J PREV MED, V54, P119, DOI 10.1016/j.amepre.2017.09.017eng
hcfmusp.relation.referenceParanthaman K, 2016, PUBLIC HEALTH, V137, P196, DOI 10.1016/j.puhe.2016.02.033eng
hcfmusp.relation.referencePascual FB, 2006, INFECT CONT HOSP EP, V27, P546, DOI 10.1086/506232eng
hcfmusp.relation.referencePulcini C, 2013, VACCINE, V31, P3943, DOI 10.1016/j.vaccine.2013.06.039eng
hcfmusp.relation.referenceSandora TJ, 2008, CLIN MICROBIOL REV, V21, P426, DOI 10.1128/CMR.00003-08eng
hcfmusp.relation.referenceSeale H, 2009, VACCINE, V27, P3022, DOI 10.1016/j.vaccine.2009.03.038eng
hcfmusp.relation.referenceSrivastav A, 2017, AM J PREV MED, V53, P537, DOI 10.1016/j.amepre.2017.04.002eng
hcfmusp.relation.referenceTaddei C, 2014, HUM VACC IMMUNOTHER, V10, P2612, DOI 10.4161/21645515.2014.970879eng
hcfmusp.relation.referenceTariq L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0800-8eng
hcfmusp.relation.referenceTeresa Aguado M, 2018, REP WHO M IMM OLD ADeng
hcfmusp.relation.referenceTuckerman JL, 2015, HUM VACC IMMUNOTHER, V11, P704, DOI 10.1080/21645515.2015.1008886eng
hcfmusp.relation.referenceVic P, 2011, ARCH PEDIATRIE, V18, P1339, DOI 10.1016/j.arcped.2011.09.029eng
hcfmusp.relation.referenceWalther K, 2015, VACCINE, V33, P2009, DOI 10.1016/j.vaccine.2015.03.013eng
hcfmusp.relation.referenceWilliams WW, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6611a1eng
hcfmusp.relation.referenceWilliams WW, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6501a1eng
hcfmusp.relation.referenceWilliams WW, 2015, MMWR-MORBID MORTAL W, V64, P95eng
hcfmusp.relation.referenceWilliams WW, 2014, MMWR-MORBID MORTAL W, V63, P95eng
hcfmusp.relation.referenceWilliams WW, 2013, MMWR-MORBID MORTAL W, V62, P66eng
hcfmusp.relation.referenceWilliams Walter W., 2012, Morbidity and Mortality Weekly Report, V61, P66eng
hcfmusp.relation.referenceWright SW, 1999, INFECT CONT HOSP EP, V20, P120, DOI 10.1086/501593eng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication4267cb5d-4584-4c46-b118-f37a5a96197a
relation.isAuthorOfPublicationd3bf06eb-3a46-4863-9639-5313d3447d1b
relation.isAuthorOfPublication0a4d59ee-2f8d-4976-b357-ea1180cc4d62
relation.isAuthorOfPublication0108ae6f-0f91-4d95-b312-369b50c4dbbe
relation.isAuthorOfPublication19d365e2-d108-4ec9-b7f9-13f46a5574da
relation.isAuthorOfPublication9e84c99a-3058-40a7-a927-d2823f19e8ab
relation.isAuthorOfPublication2178f817-7741-4b9a-9908-13ed65ab349c
relation.isAuthorOfPublicationf7c6e3e7-9e8f-4c2a-98d5-4b94881dfb25
relation.isAuthorOfPublication.latestForDiscovery4267cb5d-4584-4c46-b118-f37a5a96197a
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_RANDI_A_systematic_review_of_adult_tetanusdiphtheriaacellular_Tdap_coverage_2019.PDF
Tamanho:
345.43 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/47
Artigos e Materiais de Revistas Científicas - LIM/48
Artigos e Materiais de Revistas Científicas - ODS/03
Carregar mais